Isothiazole

Isothiazole

SCHEMBL3984653

COc1ccc(-c2cc(-c3cc(OC)c(OC)c(OC)c3)sn2)cc1SP(=O)(O)O.c1cnsc1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 5/20 0.34
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 2/20 0.34
GAA P10253 1/20 0.34
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
HTT P42858 2/20 0.32
USP2 O75604 1/20 0.32
F2 P00734 1/20 0.32
TP53 P04637 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TNFRSF1A P19438 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isothiazole SCHEMBL4092314 0.87 FYN (0.35) FYNALDH1A1KDM4ESMN1; SMN2HPGD
Isothiazole SCHEMBL3987853 0.82 TUBB4A (0.34) FYNALDH1A1KDM4ESMN1; SMN2HPGD
Isothiazole SCHEMBL3981089 0.82 SMN1; SMN2 (0.35) ALDH1A1KDM4ESMN1; SMN2HPGDHSD17B10
Isothiazole SCHEMBL3981927 0.81 NEK2 (0.38) ALDH1A1KDM4ESMN1; SMN2HPGDHSD17B10
SCHEMBL618627 0.74 TUBB4A (0.41) FYNTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL615890 0.72 TUBB4A (0.38) FYNALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL16471487 0.67 TUBB4A (0.33) FYNTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4651028 0.66 ACHE (0.46) ALDH1A1KDM4ESMN1; SMN2HPGDMAPT
Isothiazole SCHEMBL3988665 0.66 ADORA3 (0.31) ALDH1A1KDM4ESMN1; SMN2HPGDHSD17B10
SCHEMBL1167681 0.66 BRD4 (0.42) FYNALDH1A1KDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059250-A2 COMPOUNDS FOR THE TREATMENT OF ANGIOGENESIS Synta Pharmaceuticals Corporation (US) 2009-05-20 EP disclosed
WO-2008033449-A2 COMPOUNDS FOR THE TREATMENT OF ANGIOGENESIS SYNTA PHARMACEUTICALS CORP. (US) 2008-03-20 WO disclosed